Results 111 to 120 of about 1,856,875 (191)

N.B.: When citing this work, cite the original article. Original Publication:

, 2014
Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus ...
Jonas Wetterö, Christoffer Sjöwall, Christopher Sjöwall, Thomas Skogh, Helena Enocsson, Soluble Urokinase   +5 more
core  

Soluble urokinase Plasminogen Activator Receptor in Critical Illness

, 2017
Soluble urokinase Plasminogen Activator Receptor (suPAR) is a biomarker. The concentration of suPAR can be assayed in serum, plasma, cerebrospinal fluid, amnionic fluid or in other extracellular fluids. Current research has indicated that in several different conditions as well as in the general population, circulating suPAR levels are prognostic for ...
openaire   +2 more sources

Urokinase-type plasminogen activator receptor

, 2003
A polypeptide presenting an epitope cross-reactive with an epitope of urokinase-type plasminogen activator receptor, and/or having uPA binding activity, is described.
Pollanen,, Jari, Vaheri,, Antti, Dano, Keld, Pyke, Charles, Masucci, Maria, Teresa, Roldan, Ann, Louring, Behrendt, Niels, Ploug, Michael, Cubellis, Maria, Vittoria, Ronne, Ebbe, Tapiovaara,, Hannele, Lund Leif, Roge, Patthy, Laszlo, Salonen,, Eeva-Marjatta, Moller Lisbeth, Birk, Ellis, Vincent, Stephens, Ross, W, Blasi, Francesco, Appella,, Ettore, Schleuning,, Wolf-Dieter, Kristensen, Peter   +20 more
core  

Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)

, 1999
Activation of plasminogen to plasma is inhibited by preventing the binding of a receptor binding form of urokinase-type plasminogen activator to a urokinase-type plasminogen activator receptor in a mammal, thereby preventing the urokinase-type ...
Pollanen,, Jari, Vaheri,, Antti, Lund, Leif, Roege, Pyke, Charles, Masucci, Maria, Teresa, Roldan, Ann, Louring, Cubellis, Maria, Vittoria, Tapiovaara,, Hannele, Ellis,, Vincent, Rønne, Ebbe, Patthy, Laszlo, Salonen,, Eeva-Marjatta, Ploug,, Michael, Stephens, Ross, W, Blasi, Francesco, Appella,, Ettore, Schleuning,, Wolf-Dieter, Danoe,, Keld, Behrendt,, Niels, Kristensen,, Peter, Moeller, Lisbeth Birk   +20 more
core  

Significance of suPAR in glomerular diseases

Linchuang shenzangbing zazhi, 2020
The soluble urokinase-type plasminogen activator receptor(suPAR) is a new type of biomarkers, and can be used for a variety of diagnosis, evaluation and prognosis of many diseases.
RUAN Dong-dong, YUAN Jun
doaj  

Extracellular Matrix Biomarker, Fibulin-1, Is Closely Related to NT-proBNP and Soluble Urokinase Plasminogen Activator Receptor in Patients with Aortic Valve Stenosis (The SEAS Study).

, 2014
Fibulin-1, a circulating extracellular matrix glycoprotein, has been associated with arterial disease and elevated N-terminal prohormone B-type natriuretic peptide (NT-proBNP) in diabetes.
Kristian Wachtell (596861), Ronnie Willenheimer (596860), Adam Blyme (596859), Willenheimer, Ronnie, Nielsen, Olav W, Eugen-Olsen, Jesper, Olav W. Nielsen (596858), William S Argraves, Lars M. Rasmussen, Kruger, Ruan, Ronnie Willenheimer, Michael H Olsen, Lars M Rasmussen, Kristian Wachtell, Ruan Kruger, Ruan Kruger (388808), William S. Argraves (596857), Adam Blyme, Rasmussen, Lars M, William S. Argraves, Jesper Eugen-Olsen, Olsen, Michael H, Michael H. Olsen, Michael H. Olsen (388810), Wachtell, Kristian, Jesper Eugen-Olsen (39433), Argraves, William S, Blyme, Adam, Lars M. Rasmussen (425176), Olav W Nielsen, Olav W. Nielsen   +30 more
core   +1 more source

Video from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis

, 2009
Video from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung ...
Mario De Rosa (15040481), Liliana Lista (2709868), Giuseppina Votta (2141533), Maria Vincenza Carriero (8713431), Renato Franco (184143), Maria Teresa Masucci (15040478), Maria Patrizia Stoppelli (133653), Katia Bifulco (133627), Vincenzo Pavone (133641), Claudio Arra (133331), Antonio Barbieri (458558), Immacolata Longanesi-Cattani (133632), Ornella Maglio (4379920)   +12 more
core   +1 more source

Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD

, 2015
Aziz Gumus,1 Nejat Altintas,2 Halit Cinarka,1 Aynur Kirbas,3 Muge Haziroglu,1 Mevlut Karatas,1 Unal Sahin1 1Department of Pulmonary Medicine, School of Medicine, Recep Tayyip Erdogan University, Rize, Turkey; 2Department of Pulmonary Medicine ...
Kirbas A, Sahin U, Karatas M, Gumus A, Altintas N, Cinarka H, Hazıroglu M   +6 more
core  

Soluble urokinase-type plasminogen activator receptor (suPAR) in multiple respiratory diseases [PDF]

, 2015
Serum soluble urokinase-type plasminogen activator receptor (suPAR) is a glycoprotein secreted during infections and inflammation [1]. Urokinase-type plasminogen activator (uPA) is secreted by polymorphonuclear neutrophils (PMN) and macrophages; then uPA
ÜMMÜGÜLSÜM CAN
core  

Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients:A Registry-Based Cohort Study

, 2018
OBJECTIVES: Soluble urokinase plasminogen activator receptor is a prognostic biomarker associated with critical illness, disease progression, and risk of mortality.
Thomas H. Haupt, Rasmussen, Line J H, Andersen, Ove, Ladelund, Steen, Line J. H. Rasmussen, Steen Ladelund, Haupt, Thomas H, Ellekilde, Gertrude E, Gertrude E. Ellekilde, Eugen-Olsen, Jesper, Jesper Eugen-Olsen, Ove Andersen   +11 more
core   +1 more source